Resources from the same session
3819 - Could plasma EBV DNA kinetics predict long-term disease-free survival in metastatic nasopharyngeal carcinoma?
Presenter: LIU guoying
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
5658 - Predictive and Pharmacodynamic Biomarkers Associated with Phase II, selective and orally bioavailable AXL Inhibitor Bemcentinib Across Multiple Clinical Trials
Presenter: Bob Holt
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
1120 - Identification and Validation of a 23-Gene Expression Signature for Subtype Classification of Medulloblastoma
Presenter: Qinghua Xu
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
2122 - Phase I Study of CC-90011 in Patients With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL)
Presenter: Antoine Hollebecque
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
Slides
5050 - Lack of efficiency of Precision Oncology with target-based investigational treatments for patients in Early Phase clinical trials based on pre-screened molecular alterations
Presenter: Bernard Doger de Spéville
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
Poster Discussion session - Translational research 2 - Invited Discussant 62PD, 63PD, 64PD, 1832PD and 1833PD
Presenter: Giampaolo Tortora
Session: Poster Discussion session - Translational research 2
Resources:
Slides
Webcast
1375 - High tumor mutational burden (TMB) and PD-L1 have similar predictive utility in 2L+ NSCLC patients (pts) treated with anti-PD-L1 and anti-CTLA-4
Presenter: Brandon Higgs
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
4144 - Genomic profile and T cell receptor repertoire of lung adenosquamous carcinomas
Presenter: Gen Lin
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
3857 - Comparative molecular analysis between microsatellite instability-high (MSI-H) tumors with high tumor mutational burden (TMB-H) versus MSI-H tumors with TMB-intermediate/low
Presenter: Mohamed Salem
Session: Poster Discussion session - Translational research 2
Resources:
Abstract
1969 - Representative Sequencing: profiling extreme tumor diversity
Presenter: Kevin Litchfield
Session: Poster Discussion session - Translational research 2
Resources:
Abstract